India Pharma Ranbaxy Fights FDA Charges
Businessweek
Thu, 09/4/08 - 11:13 am
Vytorin may hold up long term despite recent woes
Reuters
Thu, 09/4/08 - 08:42 am
ImClone asks FDA to approve Erbitux as primary treatment for head and neck cancers
Yahoo/AP
Thu, 09/4/08 - 08:26 am
Neurocrine shares rise on elagolix trial results
Yahoo/AP
Thu, 09/4/08 - 08:25 am
Forest Labs hits 7-year low on trial results
Yahoo/AP
Thu, 09/4/08 - 08:24 am
Sciele Target the Buyout Price
Yahoo/Zacks.com
Thu, 09/4/08 - 08:22 am
Cephalon ending Provigil promotion deal with Takeda
Bizjournals.com
Thu, 09/4/08 - 08:22 am
FTC seeks more information on Teva's Barr takeover
Yahoo/AP
Thu, 09/4/08 - 08:21 am
Daiichi Sankyo reports positive data for anticoagulant drug
Pharmaceutical Business Review
Thu, 09/4/08 - 08:20 am
Akorn-Strides wins approval for two new drugs
Pharmaceutical Business Review
Thu, 09/4/08 - 08:18 am
Merck KGaA, Ablynx sign up to $484 mln drug deal
Forbes
Thu, 09/4/08 - 08:17 am
Top Statistician Says Vytorin Cancer Risk 'Not Ruled Out'
Forbes
Thu, 09/4/08 - 08:16 am
Pfizer staking millions on Alzheimer's hunch
The Day, CT
Thu, 09/4/08 - 08:16 am
Epix regains rights to MRA agent from Bayer
Marketwatch
Thu, 09/4/08 - 08:15 am
A Win For Regeneron
Forbes
Thu, 09/4/08 - 08:12 am
Flash: Vytorin Study Not A Conspiracy
Forbes
Thu, 09/4/08 - 08:13 am
UCB Pharma to Rebrand as Specialty Company
PharmExec
Thu, 09/4/08 - 08:13 am
Forest Labs, Almirall report on studies of COPD drug
Marketwatch
Wed, 09/3/08 - 11:18 am
Cyclacel Pharma in Early Cycle
Yahoo/Zacks.com
Wed, 09/3/08 - 11:16 am
Exelixis: A Platform Company for Oncology
Seeking Alpha
Wed, 09/3/08 - 11:16 am

Pages